Vigira
Clinical trial, phase IV, randomized, double-blind, controlled, in children aged 12 to 35 months, of the vaccine against seasonal influenza to estimate efficacy against influenza and other respiratory infections.
Main objective of the trial
To estimate the effectiveness of the inactivated flu vaccine with the number of episodes of acute respiratory infections, its severity and its complications in children with risk.
